Skip to content

Multiple Sclerosis Health Center

Stem Cell Transplants May Treat Aggressive MS

Study Shows Improvements in MS Patients Who Replace Bone Marrow With Stem Cells
Font Size
A
A
A
By
WebMD Health News
Reviewed by Laura J. Martin, MD

March 21, 2011 -- Replacing bone marrow with the body’s own stem cells may help patients with aggressive forms of multiple sclerosis (MS) go for years without seeing their disease progress, a new study shows.

Researchers in Greece are following a group of 35 patients who received experimental stem cell transplants for multiple sclerosis.

By purposefully wiping out the immune cells in a patient’s bone marrow with chemotherapy and then repopulating it with healthy stem cells, researchers hope the body’s immune system will stop attacking its own nerves, which eventually become so damaged from MS that they can’t properly transmit signals.

That damage can lead to wide-ranging troubles, including problems with vision, speech, weakness, coordination of movement, numbness, and pain.

According to the National Multiple Sclerosis Society, 400,000 Americans and 2.1 million people worldwide have MS.

Following Stem Cell Transplants in MS

An average of 11 years after their transplants, 25% of the patients in Greece have not seen their disease progress, the researchers report.

Among patients with active lesions on MRI scans before their transplants, indicating that they were in an inflammatory phase of the disease, 44% have not progressed.

Only 10% of patients who went into the study without evidence of ongoing inflammation were able to remain disease free.

Two patients died from transplant-related complications.

“Keeping that in mind, our feeling is that stem cell transplants may benefit people with rapidly progressive MS,” says study researcher Vasilios Kimiskidis, MD, of Aristotle University of Thessaloniki Medical School, Greece, in a news release.

“This is not a therapy for the general population of people with MS but should be reserved for aggressive cases that are still in the inflammatory phase of the disease,” he says.

The study is published in journal Neurology.

“This is the first long-term paper that’s being published on this,” says Richard Nash, MD, an oncologist and member of the Fred Hutchinson Cancer Research Center in Seattle.

Nash is part of a National Institutes of Health trial of stem cell transplants for MS, but he was not involved in the Greek study.

1 | 2 | 3

Today on WebMD

nerve damage
Learn how this disease affects the nervous system.
woman applying lotion
Ideas on how to boost your mood and self-esteem.
 
woman pondering
Get personalized treatment options.
man with hand over eye
Be on the lookout for these symptoms.
 
brain scan
ARTICLE
worried woman
ARTICLE
 
neural fiber
ARTICLE
white blood cells
VIDEO
 
sunlight in hands
ARTICLE
illustration of human spine
ARTICLE
 
muscle spasm
ARTICLE
green eyed woman with glasses
ARTICLE
 

WebMD Special Sections